Page last updated: 2024-11-12
endophenazine a
Description
endophenazine A: a phenazine antibiotic from the arthropod; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 10039975 |
| CHEMBL ID | 2071428 |
| SCHEMBL ID | 14652344 |
| MeSH ID | M0443709 |
Synonyms (9)
| Synonym |
|---|
| 9-(3-methylbut-2-enyl)phenazine-1-carboxylic acid |
| bdbm50390008 |
| CHEMBL2071428 , |
| endophenazine a |
| 1-phenazinecarboxylic acid, 9-(3-methyl-2-butenyl)- |
| 86125-71-5 |
| SCHEMBL14652344 |
| DTXSID20434646 |
| 9-(3-methylbut-2-en-1-yl)phenazine-1-carboxylic acid |
Protein Targets (1)
Inhibition Measurements
Biological Processes (14)
Molecular Functions (10)
Ceullar Components (13)
Bioassays (3)
| Assay ID | Title | Year | Journal | Article |
|---|
| AID676725 | Antimicrobial activity against Bacillus subtilis DSM 347 incubated for 5 hrs by resazurin dye based assay | 2012 | Journal of natural products, Jul-27, Volume: 75, Issue:7
| Geranylphenazinediol, an acetylcholinesterase inhibitor produced by a Streptomyces species. |
| AID676726 | Toxicity against human KIF5 cells incubated for 24 hrs by CellTiter Blue cell viability assay | 2012 | Journal of natural products, Jul-27, Volume: 75, Issue:7
| Geranylphenazinediol, an acetylcholinesterase inhibitor produced by a Streptomyces species. |
| AID676724 | Inhibition of human AChE pre-incubated for 10 mins before acetylthiocholine iodide substrate addition | 2012 | Journal of natural products, Jul-27, Volume: 75, Issue:7
| Geranylphenazinediol, an acetylcholinesterase inhibitor produced by a Streptomyces species. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.50
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 12.50 (24.57) | | Research Supply Index | 1.79 (2.92) | | Research Growth Index | 4.30 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |